A number of firms have modified their ratings and price targets on shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) recently: 2/26/2024 – Madrigal Pharmaceuticals was downgraded by analysts at B. Riley from a “neutral” rating to a “sell” rating. They now have a $155.00 price target on the stock, down previously from $204.00. 2/23/2024 – Madrigal […]
A number of firms have modified their ratings and price targets on shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) recently: 2/26/2024 – Madrigal Pharmaceuticals was downgraded by analysts at B. Riley from a “neutral” rating to a “sell” rating. They now have a $155.00 price target on the stock, down previously from $204.00. 2/23/2024 – Madrigal […]
Connor Clark & Lunn Investment Management Ltd. lowered its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 21.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 51,686 shares of the biopharmaceutical company’s stock after selling 14,075 shares during the […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective […]
Maven Securities LTD Buys New Stake in Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.